Pharmacy
Home Pharmacy
Gilead Presents Additional Data on Efficacy of Remdesivir for COVID-19
Pharma company says there is further evidence remdesivir may reduce deaths, hasten recovery
Risk for COVID-19 Increased for Adults Taking PPIs
Dose-response relationship observed; risk up 3.67-fold for those using PPIs up to twice daily
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
2008 to 2018 Saw Increase in Shingles Vaccination in Over 60s
Women equally as likely as men to have received vaccine; coverage highest for non-poor, those with higher education
Electronic Health Records Fail to Detect Many Medication Errors
Though broadly used in U.S. hospitals, EHRs fail to detect up to one-third of medication errors
Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema
VAS score reduction greater at week 16 for addition of nemolizumab versus placebo to topical agents
Long-Acting Drug Targeting Capsid Protein Promising for HIV
Reduction of viral load seen nine days after dose; sustained plasma exposure seen for more than six months
Statin Use May Cut All-Cause, CVD Mortality in Those 75 and Older
Reductions in risk seen for all-cause, CV mortality and composite of atherosclerotic CV events
February to March 2020 Saw Surge in Hydroxychloroquine Rx
Number of patients receiving hydroxychloroquine, chloroquine prescriptions climbed across the U.S.
American Cancer Society Updates HPV Vaccination Guidelines
Vaccination should be routinely offered at age 9 to 12 years; catch-up vaccination recommended through age 26
